AdaptHealth opened higher at $7.89, compared with its previous close of $7.80. In the last trading session, the stock traded between $7.62 and $7.91. It showed an upward intraday trend.
An investment of $100 made 5 years ago in AdaptHealth is now worth
$ 31.53
Resulting in a loss of
$ 68.47 (68.47%)
Note: Past profits do not guarantee future returns.
Rating from 6 Analysts
Today's Change
+$0.08 (+1.06%)
Day High
$7.91
Day Low
$7.62
Day Open
$7.89
Prev Close
$7.80
Volume
21,01,555
1W Return
8.06%
1M Return
28.07%
3M Return
39.74%
6M Return
-29.87%
1Y Return
-17.37%
Market Cap ($ Mn)
1,076
PE Ratio
-
PB Ratio
0.56
PEG Ratio
-
ROE
-4.20%
ROCE
2.41%
EPS (TTM)
$-1.13
1 Week
8.06%
1 Month
28.07%
3 Months
39.74%
6 Months
-29.87%
9 Months
-25.21%
UBS lowers AdaptHealth price target to $9 while maintaining Buy rating
UBS lowered AdaptHealth's price target from $10 to $9. The firm maintained a Buy rating on the stock. The price target reduction is $1 per share.
8 days agoAdaptHealth Q3FY26 Results: Revenue rises 10.9% to $745.6 million
Net revenue rose 10.9% YoY to $745.6 million with 12.8% organic growth. Adjusted EBITDA of $141.9 million beat guidance midpoint by $11.2 million. Largest capitated contract swung to positive EBITDA contribution from loss in Q2. Full-year revenue guidance raised to $2.88 billion-$2.9 billion; FCF guidance lowered to $55 million-$80 million.
9 days agoAdaptHealth to present at Jefferies, Baird, and Deutsche Bank conferences
AdaptHealth to present at Jefferies, Baird, and Deutsche Bank conferences in September 2026. CEO Suzanne Foster and CFO Harriss Currie to attend Jefferies and Baird events. CFO Harriss Currie and SVP Investor Relations Luke Montgomery to attend Deutsche Bank summit. Company serves approximately 4.5 million patients annually through 670 locations.
2mo agoAdaptHealth appoints Harriss Currie CFO effective Sept. 9
Harriss T. Currie appointed CFO of AdaptHealth Corp., effective Sept. 9, 2026. Currie succeeds Jason Clemens, who assists with transition through Oct. 1, 2026. Currie brings prior CFO roles at Luminex, Health Track Rx, and Impulse Dynamics. CEO Suzanne Foster welcomes Currie to lead finance team through next growth phase.
2mo agoAdaptHealth Corp faces class action probe over data breach
Edelson Lechtzin LLP investigates AdaptHealth Corp for potential class action following a data breach involving PII and PHI. The incident, disclosed to the SEC on July 2, 2026, stemmed from a social engineering attack on a third-party contractor. Patients face risks of identity theft and insurance fraud as the scope of the breach remains under investigation.
3mo agoLevi & Korsinsky probes AdaptHealth over misleading 2026 outlook
Levi & Korsinsky LLP has launched an investigation into AdaptHealth Corp. regarding misleading statements about its 2026 financial outlook. This follows a 26% stock plunge after Q2 results revealed a $0.99 GAAP loss per share, a $144.2 million goodwill impairment, and significantly reduced annual revenue and EBITDA guidance.
3mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $109.29 | -1.06% | $1,89,283.94M | 36.28 | |
| $449.53 | -0.11% | $1,55,826.88M | 42.73 | |
| $101.61 | +0.02% | $1,29,976.46M | 24.46 | |
| $318.79 | -1.70% | $1,21,360.48M | 34.27 | |
| $45.13 | +0.96% | $65,414.72M | 18.96 | |
| $105.81 | +1.73% | $60,840.75M | 53.70 | |
| $214.52 | +0.90% | $58,432.46M | 44.07 | |
| $82.60 | -1.26% | $37,346.60M | 16.49 | |
| $42.16 | +3.06% | $37,044.18M | 89.05 | |
| $72.46 | -2.16% | $35,027.16M | 54.55 | |
| $237.20 | +1.61% | $33,458.08M | 23.04 | |
| $80.35 | +0.53% | $29,964.75M | 36.04 |
An investment of $100 made 5 years ago in AdaptHealth is now worth
$ 31.53
Resulting in a loss of
$ 68.47 (68.47%)
Note: Past profits do not guarantee future returns.
